# Eradication Rate Between 1- and 2-Week Helicobacter Pylori Eradication Therapy

> **NCT02487511** · PHASE4 · COMPLETED · sponsor: **St.Paul's Hospital, Korea** · enrollment: 387 (actual)

## Conditions studied

- H.Pylori Gastrointestinal Disease

## Interventions

- **OTHER:** Duration of HP therapy

## Key facts

- **NCT ID:** NCT02487511
- **Lead sponsor:** St.Paul's Hospital, Korea
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-08-01
- **Primary completion:** 2016-08-31
- **Final completion:** 2017-01-31
- **Target enrollment:** 387 (ACTUAL)
- **Last updated:** 2017-06-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02487511

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02487511, "Eradication Rate Between 1- and 2-Week Helicobacter Pylori Eradication Therapy". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02487511. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*